bpc-157 research effects safety Would you take a drug tested only in rats? The evidence in humans for the and efficacy of is EXTREMELY limited. People need to understand what we do and don't BPC-157 and the gut–brain axis:

And specially trained phlebotomists may be permitted to give injections in certain settings

There are, however, not only successes to be counted, as late 2023 saw termination of the clinical development of VYVGART within pemphigus vulgaris and pemphigus foliaceus on account of the phase III ADDRESS trial missing its primary endpoint [254].) While VYVGART did reduce both total IgG and autoreactive DsG-targeting IgG by up to 75%, it did not lead to a sufficient clinical benefit compared to standard-of-care treatment with corticosteroids

If you find your diet is not rich in foods that have B12, you may want to look more into these injections

An open-label, phase I pilot study conducted by Hirschowitz EA et al